CoreCap Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Buy
661
+18
+3% +$357 ﹤0.01% 1981
2026
Q1
$12.4K Buy
643
+9
+1% +$177 ﹤0.01% 1875
2025
Q4
$12K Buy
634
+10
+2% +$185 ﹤0.01% 1896
2025
Q3
$11.6K Buy
624
+9
+1% +$168 ﹤0.01% 1881
2025
Q2
$11.3K Sell
615
-4
-0.6% -$71 ﹤0.01% 1819
2025
Q1
$10.8K Buy
619
+25
+4% +$422 ﹤0.01% 1783
2024
Q4
$10.3K Buy
594
+9
+2% +$164 ﹤0.01% 1767
2024
Q3
$10.9K Buy
585
+10
+2% +$169 ﹤0.01% 1779
2024
Q2
$8.85K Buy
575
+12
+2% +$171 ﹤0.01% 1079
2024
Q1
$8.31K Buy
+563
New +$7.8K ﹤0.01% 1788
2022
Q4
$6.23K Buy
+500
New +$6.38K ﹤0.01% 1690
2022
Q3
Sell
-479
Closed -$7K 1784
2022
Q2
$7K Buy
+479
New +$6.4K ﹤0.01% 1581
2022
Q1
Sell
-459
Closed -$6K 1785
2021
Q4
$6K Buy
+459
New +$6.5K ﹤0.01% 1715

Other funds holding SBRA

CoreCap Advisors's SBRA Position: Q2 2026 in Review

CoreCap Advisors increased its Sabra Healthcare REIT (SBRA) stake by 2.8% in Q2 2026, buying an estimated $357 and bringing the position to 661 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

CoreCap Advisors first reported a position in SBRA in Q4 2021 and has held it in 13 quarters since. 39 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • CoreCap Advisors held 661 shares of Sabra Healthcare REIT worth $12.9K as of Q2 2026.
  • CoreCap Advisors bought 18 Sabra Healthcare REIT shares in Q2 2026, an estimated $357.
  • Sabra Healthcare REIT made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1981 holding.
  • CoreCap Advisors first reported a position in Sabra Healthcare REIT in Q4 2021 and has held it in 13 quarters since.
  • 39 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.